Technical Analysis for AIMD - Ainos, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 20 DMA | Bearish | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Down | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| 50 DMA Resistance | Bearish | -12.30% | |
| Crossed Above 20 DMA | Bullish | -12.30% | |
| Stochastic Buy Signal | Bullish | -12.30% | |
| Pocket Pivot | Bullish Swing Setup | -12.30% | |
| Wide Range Bar | Range Expansion | -12.30% | |
| Upper Bollinger Band Touch | Strength | -12.30% |
| Alert | Time |
|---|---|
| Down 5% | about 22 hours ago |
| Down 3% | about 22 hours ago |
| Down 2 % | about 22 hours ago |
| Down 1% | about 22 hours ago |
| Fell Below 20 DMA | about 22 hours ago |
Get a Trading Sidekick!
- Earnings date: 08/09/2024
Ainos, Inc. Description
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. The company offers COVID-19 antigen rapid test kit and Ainos' cloud-based test management App, a cloud-based test management platform comprising an antigen rapid test kit, a personal application, and an enterprise app; COVID-19 nucleic acid test; volatile organic compounds point-of-care testing; Very Low-Dose Oral Interferon Alpha, a low-dose oral interferon alpha formulation based IFN-a's broad treatment applications; and Synthetic RNA developing a SRNA technology platform in Taiwan. The company was formerly known as Amarillo Biosciences, Inc. and changed its name to Ainos, Inc. in May 2021. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California.
Classification
Keywords: Medicine Clinical Medicine Disease Medical Test Cytokine Interferon Antivirals Point Of Care Testing
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.1 |
| 52 Week Low | 0.7749 |
| Average Volume | 832,275 |
| 200-Day Moving Average | 1.79 |
| 50-Day Moving Average | 0.95 |
| 20-Day Moving Average | 0.85 |
| 10-Day Moving Average | 0.84 |
| Average True Range | 0.11 |
| RSI (14) | 45.65 |
| ADX | 39.16 |
| +DI | 37.99 |
| -DI | 10.23 |
| Chandelier Exit (Long, 3 ATRs) | 0.85 |
| Chandelier Exit (Short, 3 ATRs) | 1.09 |
| Upper Bollinger Bands | 0.95 |
| Lower Bollinger Band | 0.75 |
| Percent B (%b) | 0.36 |
| BandWidth | 23.15 |
| MACD Line | -0.03 |
| MACD Signal Line | -0.04 |
| MACD Histogram | 0.0076 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 0.97 | ||||
| Resistance 3 (R3) | 0.98 | 0.94 | 0.95 | ||
| Resistance 2 (R2) | 0.94 | 0.90 | 0.94 | 0.94 | |
| Resistance 1 (R1) | 0.88 | 0.88 | 0.86 | 0.87 | 0.93 |
| Pivot Point | 0.84 | 0.84 | 0.83 | 0.84 | 0.84 |
| Support 1 (S1) | 0.78 | 0.80 | 0.76 | 0.77 | 0.72 |
| Support 2 (S2) | 0.74 | 0.78 | 0.74 | 0.71 | |
| Support 3 (S3) | 0.68 | 0.74 | 0.70 | ||
| Support 4 (S4) | 0.67 |
